Every laboratory program is developed with regulatory compliance as a foundational design principle. Our implementation framework is built to align with the federal and state regulatory requirements governing laboratory services, physician self-referral, and healthcare arrangements.
This page is for informational purposes only and does not constitute legal advice. All prospective clients are strongly required to consult qualified healthcare legal counsel prior to entering any laboratory arrangement. Program structures are subject to regulatory review and jurisdictional variation.
The Stark Law is a strict liability statute—there is no intent requirement for a violation to occur. A physician who has a financial relationship with a laboratory entity (ownership interest, investment interest, or compensation arrangement) may not refer Medicare or Medicaid patients to that entity for clinical laboratory services unless a specific exception is met.
Clinical laboratory services are among the "designated health services" (DHS) covered by the Stark Law. All laboratory programs involving physician financial relationships require exception analysis prior to implementation.
Several Stark Law exceptions may be applicable to physician laboratory arrangements depending on the program structure, ownership model, and practice setting. Exception requirements are specific and technical—each element must be independently satisfied.
Stark Law violations can result in denial of payment for referred services, repayment of improper payments, civil monetary penalties, and exclusion from federal healthcare programs. Strict liability means violations can occur without any intent to violate the law. Proactive compliance review is essential before any arrangement is implemented.
The AKS is a criminal statute that prohibits knowingly and willfully offering, paying, soliciting, or receiving anything of value to induce or reward referrals or the generation of business reimbursable by federal healthcare programs. Unlike the Stark Law, the AKS requires intent and applies broadly across all healthcare arrangements—not just physician self-referral.
Laboratory arrangements must be structured to ensure that no compensation is tied to referral volume or value, and that no remuneration is offered or received in connection with any patient referral to the laboratory.
The OIG has established regulatory safe harbors that protect certain arrangements from AKS prosecution when all safe harbor criteria are met. Safe harbor protection is not automatic—all requirements must be satisfied and documented.
All compensation arrangements in our programs are structured at fair market value, with no component tied to referral volume or value. No remuneration is offered or received in connection with any patient referral. Independent legal review of all compensation arrangements is required before program implementation.
The type of CLIA certificate required depends on the complexity of testing performed. Most in-office laboratory programs require at minimum a Certificate of Compliance or Certificate of Accreditation for moderate- or high-complexity testing. The appropriate certificate is determined during the program design phase.
CLIA-certified laboratories must maintain ongoing compliance with quality standards covering personnel qualifications, quality control, proficiency testing, quality assurance, and record-keeping. These are ongoing requirements—not one-time certification standards.
CAP accreditation is a widely recognized standard of laboratory quality that satisfies CLIA requirements through deemed status. CAP accreditation preparation is included in our regulatory pathway coordination services for programs pursuing accreditation-level certification.
CAP readiness coordination includes gap analysis, policy and procedure review, proficiency testing selection, and pre-inspection preparation to support successful accreditation outcomes.
CMS and commercial payers require that laboratory tests be medically necessary and that medical necessity be documented in the patient's medical record. Ordering without documented clinical indication, ordering based on standing orders without individualized review, or ordering tests not aligned with a patient's clinical presentation creates billing compliance risk.
Accurate CPT coding, appropriate use of modifiers, and compliant claim submission are essential to billing compliance and audit readiness. Coding errors—whether upward or downward—carry compliance risk. All billing practices must align with CMS guidelines and applicable Local Coverage Determinations (LCDs).
Laboratory services are a frequent target of CMS Recovery Audit Contractor (RAC) reviews, OIG investigations, and commercial payer audits. Audit readiness requires complete documentation, accurate coding, and a functional compliance program. These requirements are integrated into program design and operational training from the outset.
State laboratory laws, self-referral statutes, and scope-of-practice requirements vary significantly by jurisdiction. Federal compliance alone is not sufficient. Every program includes a review of applicable state-level regulatory requirements for each operating location.
Many states require separate laboratory licensure in addition to federal CLIA certification. Licensure requirements, application timelines, and renewal obligations vary by state. All applicable state laboratory license requirements are identified as part of the regulatory pathway coordination phase.
Several states have enacted self-referral laws that are broader than the federal Stark Law in scope or application—covering additional provider types, additional designated services, or commercial (non-Medicare/Medicaid) payers. State self-referral law compliance is reviewed in parallel with federal Stark Law analysis.
State laws governing who may own laboratory entities, directorship requirements, and scope of practice for laboratory personnel vary by jurisdiction. Applicable state professional licensing requirements and ownership restrictions are assessed as part of program design.
The regulatory frameworks governing clinical laboratory arrangements—particularly those involving physician financial relationships—are among the most complex in healthcare law. The Stark Law is a strict liability statute; the AKS carries criminal penalties. The consequences of non-compliance can include repayment obligations, exclusion from federal programs, and criminal prosecution.
White Oaks Medical Solutions provides operational and regulatory coordination support. We do not practice law and we do not provide legal advice. Engagement of qualified healthcare legal counsel is a required component of any laboratory program—not optional.
Ownership and financial arrangement structure; Stark Law exception applicability; AKS safe harbor analysis; compensation arrangement fair market value; state law compliance; corporate practice of medicine issues; and any revenue-sharing or management agreements.
Legal counsel should be engaged during the program design phase—before any ownership structure is established, before any compensation arrangement is agreed to, and before any referral arrangement is implemented. Early engagement reduces risk and avoids costly restructuring.
Regulatory requirements evolve. Arrangements that were compliant when implemented may require review as laws, regulations, and OIG guidance change. Ongoing legal oversight is a best practice for any laboratory arrangement involving physician financial relationships.
General orientation on frequently asked regulatory questions. These responses do not constitute legal advice.
This website, including this compliance page, is provided for general informational purposes only. Nothing contained herein constitutes legal, financial, clinical, or reimbursement advice. The information presented does not create an attorney-client relationship and should not be relied upon as legal guidance.
All services described herein are subject to applicable federal and state laws including, but not limited to, the Stark Law (42 U.S.C. §1395nn), Anti-Kickback Statute (42 U.S.C. §1320a-7b(b)), CLIA regulations (42 C.F.R. Part 493), and applicable CMS billing standards and Local Coverage Determinations. All arrangements are structured to comply with applicable legal and regulatory requirements, subject to independent legal review.
All prospective clients are strongly required to retain qualified healthcare legal counsel prior to entering into any laboratory arrangement. Program structures described herein are subject to regulatory review, legal counsel analysis, contractual agreement, and operational feasibility determination. State-specific laws vary significantly by jurisdiction; state law review is required for each operating location.
No guarantees of financial performance, reimbursement, or clinical outcomes are made or implied. Financial projections provided during the feasibility process are estimates based on stated assumptions and do not constitute guarantees. Actual results will vary based on patient volume, payer mix, medical necessity documentation, billing compliance, and a range of other variables.
White Oaks Medical Solutions does not practice law and does not provide legal advice. Any regulatory or compliance information provided is for general informational purposes only and must be independently verified by qualified legal counsel.
All submissions are strictly confidential. We use your answers to determine program eligibility and prepare a personalized response. Takes approximately 5–7 minutes.